Expert Insights
Content Hubs
Themes
Active ETFs
Free Cash Flow
Alternatives
Future ETFs
Artificial Intelligence
Innovative ETFs
China Insights
Institutional Income Strategies
CoinShares
Leveraged & Inverse
Core Strategies
Market Insights
Crypto
Market Outlooks
Disruptive Technology
Modern Alpha
Energy Infrastructure
Nuclear Energy
ETF Building Blocks
Portfolio Strategies
ETF Investing
Sector Investing
ETF Strategist
Tax Efficient Income
Financial Literacy
Thematic Investing
Fixed Income
Asset Class
Equity
Emerging Market Equities
Int'l Developed
U.S. Equity
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Gold/Silver/Critical Materials
Cryptocurrency
Currency
Volatility
ETF Ecosystem
ETFs in Canada
Market Outlook
Exchange
CoinShares
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
IEMG – iShares Core MSCI Emerging Markets ETF
EEM – iShares MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
Gaining Perspective
ETF 360 Video Series
Sectors
Sector Investing Content Hub
Sector Power Rankings
XLK
XLE
XLI
XLC
XLU
XLF
XLY
XLV
XLP
XLB
XLRE
Events
Asset Allocation Summit
Midyear Market Outlook
2027 Market Outlook
Q2 Market Outlook
Winter Symposium
Company
About VettaFi
Get VettaFi’ed
XBI
Featured
Choosing the Right Biotech ETF Exposure
By
Tom Lydon
April 20, 2012
Featured
Biotech ETFs Soar on Human Genome Bid, Gilead Drug Results
By
John Spence
April 19, 2012
Featured
Biotech ETFs Break Out
By
John Spence
January 19, 2012
Featured
Teva, Cephalon Boost Biotech ETFs
By
John Spence
May 2, 2011
Featured
April ETF Performance Report
By
Tom Lydon
April 29, 2011
Featured
Biogen Earnings, Drug Data to Lift Biotech ETFs
By
John Spence
April 21, 2011
Featured
ETFs And A Global Approach Help Investors Access Biotech
By
Tom Lydon
March 11, 2011
Featured
5 Biotechnology ETFs to Play Innovation
By
Tom Lydon
February 22, 2011
Featured
ETFs Turn Sunny Side Up on M&A and Earnings
By
Tom Lydon
February 16, 2011
Featured
Sector ETFs to Play the State of the Union Address
By
Tom Lydon
January 26, 2011
Featured
Dissipate the Risk In Biotechnology With ETFs
By
Tom Lydon
January 18, 2011
Featured
Play the Booming Biotech Sector With ETFs
By
Tom Lydon
December 21, 2010
Equity ETFs
Deal-Making Drives ETFs Higher
By
Tom Lydon
December 21, 2010
Featured
Why Health Care ETFs May Be In the Clear
By
Tom Lydon
November 10, 2010
Featured
Biotech ETFs May Soon Face Challenges
By
Tom Lydon
November 6, 2010
Featured
Biotech ETFs Readying to Deliver the Goods
By
Tom Lydon
November 2, 2010
Featured
5 Things That Drive Biotech ETFs
By
Tom Lydon
October 21, 2010
Featured
Biotech ETFs:The Better Way to Play
By
Tom Lydon
October 11, 2010
Previous
1
…
12
13
14
15
16
Next
X